Prostate Cancer P D:冷冻疗法、射波刀或者积极全面的监控后,患有前列腺癌男性的病人报道的生活质量情况研究

2017-12-19 AlexYang MedSci原创

技术的进步使得最小化前列腺癌侵入治疗形式获得了成功,比如射波刀和冷冻疗法。最近,有研究人员调查了在射波刀(KC)或者冷冻疗法之后,病人报道的排尿功能、排便习惯和性功能情况,并且与积极全面的监控(AHS)病人进行了比较。研究包括了279名病人(767调查集)。研究发现,不同的治疗方法在排尿功能得分方面没有差异。射波刀组在治疗后早期具有显著更低的排尿习惯得分(第二年平均差:-5.4,P<0.01

技术的进步使得最小化前列腺癌侵入治疗形式获得了成功,比如射波刀和冷冻疗法。最近,有研究人员调查了在射波刀(KC)或者冷冻疗法之后,病人报道的排尿功能、排便习惯和性功能情况,并且与积极全面的监控(AHS)病人进行了比较。

研究包括了279名病人(767调查集)。研究发现,不同的治疗方法在排尿功能得分方面没有差异。射波刀组在治疗后早期具有显著更低的排尿习惯得分(第二年平均差:-5.4,P<0.01),但是在第4年回到了AHS水平得分。冷冻疗法病人在治疗后起始时牌匾功能得分较低,但是并不显著,随后得分提高并且接近AHS得分。另外,射波刀组(第1年平均差:26.7, P<0.001)和冷冻疗法组(35.4, P<0.001)与AHS比较具有更低的性功能得分,但是随后逐渐提高,并且在第3年与AHS组不再具有显著的差异。在射波刀组(18.45, P<0.01)和冷冻疗法组中(14.6, P<0.05),具有激素治疗历史的病人要比那些没有接受激素治疗的病人具有更低的性功能得分。最后,研究人员指出,起始较低的排便习惯和性功能得分之后,射波刀或者冷冻疗法治疗的病人与AHS病人相比,QoL并没有显著的差异。这些结果突出了射波刀和冷冻疗法在局限于器官内前列腺癌治疗中的优势。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1650154, encodeId=902e1650154a5, content=<a href='/topic/show?id=3fb03112e75' target=_blank style='color:#2F92EE;'>#冷冻疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31127, encryptionId=3fb03112e75, topicName=冷冻疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Sun Dec 31 06:47:00 CST 2017, time=2017-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791522, encodeId=06381e91522ed, content=<a href='/topic/show?id=b77f14e4541' target=_blank style='color:#2F92EE;'>#Prostate Ca#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14745, encryptionId=b77f14e4541, topicName=Prostate Ca)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Wed Jul 11 23:47:00 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364269, encodeId=081113642696c, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Thu Dec 21 11:47:00 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601950, encodeId=4ead1601950bf, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Thu Dec 21 11:47:00 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271080, encodeId=d5872e108023, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Thu Dec 21 06:44:40 CST 2017, time=2017-12-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1650154, encodeId=902e1650154a5, content=<a href='/topic/show?id=3fb03112e75' target=_blank style='color:#2F92EE;'>#冷冻疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31127, encryptionId=3fb03112e75, topicName=冷冻疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Sun Dec 31 06:47:00 CST 2017, time=2017-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791522, encodeId=06381e91522ed, content=<a href='/topic/show?id=b77f14e4541' target=_blank style='color:#2F92EE;'>#Prostate Ca#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14745, encryptionId=b77f14e4541, topicName=Prostate Ca)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Wed Jul 11 23:47:00 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364269, encodeId=081113642696c, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Thu Dec 21 11:47:00 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601950, encodeId=4ead1601950bf, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Thu Dec 21 11:47:00 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271080, encodeId=d5872e108023, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Thu Dec 21 06:44:40 CST 2017, time=2017-12-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1650154, encodeId=902e1650154a5, content=<a href='/topic/show?id=3fb03112e75' target=_blank style='color:#2F92EE;'>#冷冻疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31127, encryptionId=3fb03112e75, topicName=冷冻疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Sun Dec 31 06:47:00 CST 2017, time=2017-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791522, encodeId=06381e91522ed, content=<a href='/topic/show?id=b77f14e4541' target=_blank style='color:#2F92EE;'>#Prostate Ca#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14745, encryptionId=b77f14e4541, topicName=Prostate Ca)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Wed Jul 11 23:47:00 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364269, encodeId=081113642696c, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Thu Dec 21 11:47:00 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601950, encodeId=4ead1601950bf, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Thu Dec 21 11:47:00 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271080, encodeId=d5872e108023, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Thu Dec 21 06:44:40 CST 2017, time=2017-12-21, status=1, ipAttribution=)]
    2017-12-21 lsndxfj
  4. [GetPortalCommentsPageByObjectIdResponse(id=1650154, encodeId=902e1650154a5, content=<a href='/topic/show?id=3fb03112e75' target=_blank style='color:#2F92EE;'>#冷冻疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31127, encryptionId=3fb03112e75, topicName=冷冻疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Sun Dec 31 06:47:00 CST 2017, time=2017-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791522, encodeId=06381e91522ed, content=<a href='/topic/show?id=b77f14e4541' target=_blank style='color:#2F92EE;'>#Prostate Ca#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14745, encryptionId=b77f14e4541, topicName=Prostate Ca)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Wed Jul 11 23:47:00 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364269, encodeId=081113642696c, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Thu Dec 21 11:47:00 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601950, encodeId=4ead1601950bf, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Thu Dec 21 11:47:00 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271080, encodeId=d5872e108023, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Thu Dec 21 06:44:40 CST 2017, time=2017-12-21, status=1, ipAttribution=)]
    2017-12-21 sunylz
  5. [GetPortalCommentsPageByObjectIdResponse(id=1650154, encodeId=902e1650154a5, content=<a href='/topic/show?id=3fb03112e75' target=_blank style='color:#2F92EE;'>#冷冻疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31127, encryptionId=3fb03112e75, topicName=冷冻疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Sun Dec 31 06:47:00 CST 2017, time=2017-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1791522, encodeId=06381e91522ed, content=<a href='/topic/show?id=b77f14e4541' target=_blank style='color:#2F92EE;'>#Prostate Ca#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14745, encryptionId=b77f14e4541, topicName=Prostate Ca)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a691420, createdName=30397604, createdTime=Wed Jul 11 23:47:00 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1364269, encodeId=081113642696c, content=<a href='/topic/show?id=7c5615628ad' target=_blank style='color:#2F92EE;'>#ROS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15628, encryptionId=7c5615628ad, topicName=ROS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acc3210, createdName=lsndxfj, createdTime=Thu Dec 21 11:47:00 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601950, encodeId=4ead1601950bf, content=<a href='/topic/show?id=2f801469e57' target=_blank style='color:#2F92EE;'>#PRO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14697, encryptionId=2f801469e57, topicName=PRO)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a60b18898917, createdName=sunylz, createdTime=Thu Dec 21 11:47:00 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271080, encodeId=d5872e108023, content=一起学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/TDiaAWyicHgedzX3wKo3qcxudVJib7AfibfvNeufHRF2jG3Bw8MmZyWjIhtBV1mpJI7Sy9n7RcBKK5t3CuOKuOFxkg/0, createdBy=dd702206933, createdName=wzb521zf, createdTime=Thu Dec 21 06:44:40 CST 2017, time=2017-12-21, status=1, ipAttribution=)]
    2017-12-21 wzb521zf

    一起学习学习

    0

相关资讯

Sci Rep:MIC-1作为一个基于血清的前列腺癌预测因子的相关性研究

为了减少在不同的研究中,关于巨噬细胞抑制因子-1(MIC-1)在前列腺癌(PC)、良性前列腺增生(BPH)和健康对照中的表达水平中相互不同观察结果的争议,最近,有研究人员设计了一个双盲的研究。研究包括了240例来自PC、BPH和HC病人的血清。研究人员利用蛋白免疫印迹技术(WB)和基于ELISA技术的方法评估了MIC-1在PC、BPH和HC中的表达水平。研究发现,WB和ELISA技术评估阐释了MI

Prostate Cancer P D :基线前列腺萎缩与更小的肿瘤体积相关

前列腺萎缩(PA)在前列腺生物活检中经常遇到。之前的研究表明了PA也许与更低的PCa风险相关。然而,是否PA与更小的、更不具有侵入性的和更低程度晚期肿瘤相关仍旧未知。因此,研究人员探究了是否在最初前列腺(PCa)活检阴性的男性中,基线PA的存在和严重度与PCa体积在第2年和第4年重复活检相关。研究人员在927名年龄在50-75岁男性且具有阴性PCa基线活检和2年和4年后重复PCa活检阳性的群体中进

Sci Rep:类器官模拟在不同前列腺癌进化阶段,维他命E的不同影响

在硒和维他命E癌症预防试验(SELECT)中,维他命E能够通过未知的机制来增加前列腺癌风险,然而,硒并没有展现出相关作用。最近,有研究人员确定了SELECT补充剂对良性(初级)、恶化前(RWPE-1)和恶化的(LNCaP)前列腺上皮类器官的影响。研究发现,虽然补充剂在癌症类器官中能够减少癌细胞增殖和诱导细胞死亡,它们对良性类器官并没有影响。与之不同,维他命E能够增强在恶化前类器官中的细胞增殖和生存

J Hum Genet:抗肿瘤miR-205-5p对HMGB3的调控能够抑制癌细胞入侵,并且与前列腺癌病理有关

之前的研究确定了miRNA在前列腺癌(PCa)中的意义,并且阐释了miR-205-5p在PCa组织中显著减少,并且能够作为一个抗肿瘤的miRNA。最近,有研究人员进行了旨在在受抗肿瘤miR-205-5p调控的PCa细胞中,鉴定出致瘤基因和相关信号通路的研究。全基因组基因表达分析和生物信息学miRNA数据库查询展示了37个基因为miR-205-5p调控的假定靶标。在这些基因中,其中的7个(HMGB3

Oncogenesis:多西环素能够通过内质网应激反应对具有癌症干细胞特性的细胞进行选择性的诱导凋亡

肿瘤异质性能够追溯到癌症干细胞(CSCs)的一个小的集合,这个小的集合可以来源自一个单独的干细胞并且展现化学抵抗性。最近的研究表明CSCs对线粒体靶向抗生素敏感,比如多西环素。然而,癌症细胞怎样形成球体以及抗生素怎样抑制CSC增殖还所知甚少。最近,有研究人员展示了在球体形成试验条件下,前列腺癌细胞获得了类似CSC特性:促进心里替呼吸链活性、特征CSC标记的表达和对抗癌药物的抗性。更多的是,那些类似

Sci Rep:前列腺癌中,miR-205在正常上皮中的高表达与生化失败相关

由于不充足的预后工具,对恶性前列腺癌(PC)预测的失败导致了病人只能选择放射治疗,因此仍旧是一个未解决的挑战。同时,这也导致了过度的放射治疗。更好的预后工具是急切需要的。之前研究发现,MicroRNAs(miRs)是细胞信号通路的重要调控因子,并能够导致基因表达的改变。并且,在PC中miR-205的表达下调,并可以作为肿瘤抑制子起作用。最近,有研究人员在一个大的和具有详细描述的535名挪威群体前列